Glucose-lowering and heart failure: risks of errors

Lancet Diabetes Endocrinol. 2015 May;3(5):310-2. doi: 10.1016/S2213-8587(15)00077-7. Epub 2015 Mar 17.

Authors

Iwan C C van der Horst¹, Frederik Keus²

Affiliations

¹ University of Groningen, University Medical Center Groningen, Department of Critical Care, Groningen 9700 RB, Netherlands. Electronic address: [email protected].
² University of Groningen, University Medical Center Groningen, Department of Critical Care, Groningen 9700 RB, Netherlands.

PMID: 25791289
DOI: 10.1016/S2213-8587(15)00077-7

No abstract available

Publication types

Comment

MeSH terms

Diabetes Mellitus, Type 2 / epidemiology*
Heart Failure / chemically induced*
Heart Failure / epidemiology*
Humans
Hypoglycemic Agents / adverse effects*

Substances

Hypoglycemic Agents